Have Your Company Be a Newsmaker at DCAT Week

Does your company have major company news that it would like to share at DCAT Week? DCAT Member Companies are invited to apply to present at the Member Company Announcement Forum, a valuable platform in which senior executives make significant news announcements.

Does your company have major company news that it would like to share at DCAT Week? DCAT Member Companies are invited to apply to present at the Member Company Announcement Forum, a valuable platform in which senior executives make significant news announcements.

Hear from senior executives on major company news
The DCAT Member Company Announcement Forum is a much-anticipated program at DCAT Week in which senior executives from DCAT Member Companies make major news announcements to DCAT Week’s influential attendees and the industry press.

Exclusive to DCAT Member Companies, the DCAT Member Company Announcement Forum is a valuable platform to highlight key news developments from your company occurring in 2026* in the following areas:

  • Mergers and acquisitions (M&A), including post-M&A integration;
  • Significant and critical capital expansions for manufacturing and development capacity across the bio/pharmaceutical manufacturing value chain—raw materials, chemicals, processing aids, excipients, and other inputs; drug substances (small molecules & biologics); drug products; and packaging; and
  • Other key corporate strategic developments occurring in 2025 and beyond.

*Note: News announcements must be from January 2026 forward. If an announcement was first made prior to January 2026, updated information occurring in 2026 or beyond must be included. In the case of M&A, this can include deal closing or post-M&A integration occurring in 2026 or beyond, and for expansions, updated timelines for completion and launch occurring in 2026 or beyond.

Who Can Apply & Deadlines
The Member Company Announcement Forum is open to all Registered DCAT Member Companies: bio/pharma companies, CDMOs/CMOs, and other suppliers—large, mid-sized, and small companies. Applications are due Monday February 2, 2026. Further information, including the online applications, may be found here

Applications are reviewed by the DCAT Member Company Announcement Forum Oversight Committee, which selects those companies receiving podium time at DCAT Week based on the following criteria: news priority, criticality of the news development, and interest to DCAT Member Companies.

Where & When
The Member Company Announcement Forum will be held during DCAT Week on Monday March 23, 2026 (9:00-11:30 AM) at the InterContinental New York Barclay, Grand Ballroom (2nd Floor). The program is complimentary and exclusive to DCAT Member Companies. To register to attend, click here

Recent Feature Articles

Bio/Pharma Outlook 2026: The Year Ahead

By
What are the key issues on the bio/pharmaceutical industry’s radar in 2026? DCAT Value Chain Insights weighs in on the key trends and developments shaping the industry in the year ahead: from manufacturing and supply lines to product innovation and new drug development.

CDMOs/CMOs: The Movers and Shakers of 2025

By
As 2025 comes to a close, what were the key developments—expansions and M&A—from CDMOs/CMOs this year? DCAT Value Chain Insights looks at the companies and moves that topped the headlines this year.

EU Policymakers Take Next Step in Key Pharma Reforms

By
The European Commission, the European Parliament, and the Council of the European Union, have agreed to a proposal for the EU’s landmark pharma legislation, setting the stage for major reforms.

2025: The Bio/Pharma Industry’s Year in Review

By
Without question, US-imposed tariffs and ensuing trade deals and the impact on the bio/pharma industry was the number one news story in 2025, going hand-in-hand with US manufacturing investments and drug pricing reforms. What else made the news?